Incidence, Clinical Predictors and Treatment Outcomes of Necrotizing Otitis Externa: Identifying Regional and Remote Risk in Tropical North Queensland.

IF 1.7 3区 医学 Q3 CLINICAL NEUROLOGY
James Nightingale, Mark Mackenzie, Shane Anderson
{"title":"Incidence, Clinical Predictors and Treatment Outcomes of Necrotizing Otitis Externa: Identifying Regional and Remote Risk in Tropical North Queensland.","authors":"James Nightingale, Mark Mackenzie, Shane Anderson","doi":"10.1097/MAO.0000000000005093","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate incidence, presentation, microbiology, and predictors of necrotizing otitis externa (NOE) outcomes in tropical North Queensland, Australia.</p><p><strong>Study design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>Townsville University Hospital.</p><p><strong>Patients: </strong>Forty-six NOE patients (January 2017-March 2025).</p><p><strong>Interventions: </strong>Review of demographic, clinical, and microbiology data. Outcomes stratified by geography (local <50 km vs. regional/remote >50 to >400 km) and indigenous status, with identification of prognostic factors.</p><p><strong>Main outcome measures: </strong>Incidence, relapse, treatment failure, disease-specific survival, and overall survival per 2024 core outcome set necrotizing otitis externa (COSNOE) guidelines.</p><p><strong>Results: </strong>A total of 46 patients with NOE were diagnosed between January 2017 and March 2025. Over the 8-year study period, NOE incidence trended higher, peaking at 1.21 per 100,000. Patients were elderly (78 years), male (82.6%), and diabetic (71.7%). Pseudomonas aeruginosa (82.2%) dominated alongside high fungal (64.4%) and polymicrobial (71.1%) infections. Advanced age, cranial neuropathy, and advanced disease predicted adverse outcomes (P < 0.05). Culture-negativity correlated with advanced skull base disease (P = 0.045). Indigenous patients (19.5%) were significantly younger (P < 0.001) with equivalent comorbidity burden (P = 0.719). Overall relapse was 21.7%. C-reactive protein <15 mg/L yielded a 91.3% negative predictive value for recurrence (P = 0.026). Regional/remote residence was an independent predictor of relapse (hazard ratio: 10.47, P = 0.027), yielding a lower relapse-free survival compared with local patients (61.1% vs 88.5%; P = 0.044). Twelve-month treatment success was 80.4%, with 1-year disease-specific mortality 11.1% and overall disease-specific survival 84.7%.</p><p><strong>Conclusion: </strong>NOE incidence is rising in North Queensland, driven by distinct tropical and social determinants in a high-risk population. With increasing incidence and high relapse rates, further research is required to improve outcomes for high-risk communities.</p>","PeriodicalId":19732,"journal":{"name":"Otology & Neurotology","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Otology & Neurotology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MAO.0000000000005093","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate incidence, presentation, microbiology, and predictors of necrotizing otitis externa (NOE) outcomes in tropical North Queensland, Australia.

Study design: Retrospective cohort study.

Setting: Townsville University Hospital.

Patients: Forty-six NOE patients (January 2017-March 2025).

Interventions: Review of demographic, clinical, and microbiology data. Outcomes stratified by geography (local <50 km vs. regional/remote >50 to >400 km) and indigenous status, with identification of prognostic factors.

Main outcome measures: Incidence, relapse, treatment failure, disease-specific survival, and overall survival per 2024 core outcome set necrotizing otitis externa (COSNOE) guidelines.

Results: A total of 46 patients with NOE were diagnosed between January 2017 and March 2025. Over the 8-year study period, NOE incidence trended higher, peaking at 1.21 per 100,000. Patients were elderly (78 years), male (82.6%), and diabetic (71.7%). Pseudomonas aeruginosa (82.2%) dominated alongside high fungal (64.4%) and polymicrobial (71.1%) infections. Advanced age, cranial neuropathy, and advanced disease predicted adverse outcomes (P < 0.05). Culture-negativity correlated with advanced skull base disease (P = 0.045). Indigenous patients (19.5%) were significantly younger (P < 0.001) with equivalent comorbidity burden (P = 0.719). Overall relapse was 21.7%. C-reactive protein <15 mg/L yielded a 91.3% negative predictive value for recurrence (P = 0.026). Regional/remote residence was an independent predictor of relapse (hazard ratio: 10.47, P = 0.027), yielding a lower relapse-free survival compared with local patients (61.1% vs 88.5%; P = 0.044). Twelve-month treatment success was 80.4%, with 1-year disease-specific mortality 11.1% and overall disease-specific survival 84.7%.

Conclusion: NOE incidence is rising in North Queensland, driven by distinct tropical and social determinants in a high-risk population. With increasing incidence and high relapse rates, further research is required to improve outcomes for high-risk communities.

坏死性外耳炎的发病率、临床预测因素和治疗结果:确定热带北昆士兰地区和偏远地区的风险。
目的:评估澳大利亚昆士兰北部热带地区坏死性外耳炎(NOE)的发病率、表现、微生物学和预测因素。研究设计:回顾性队列研究。单位:汤斯维尔大学医院。患者:NOE患者46例(2017年1月- 2025年3月)。干预措施:回顾人口统计学、临床和微生物学数据。结果按地理(当地50至400公里)和土著状态分层,并确定预后因素。主要结局指标:发病率、复发、治疗失败、疾病特异性生存和总生存(2024核心结局集外源性坏死性中耳炎(COSNOE)指南)结果:2017年1月至2025年3月共诊断NOE患者46例。在8年的研究期间,NOE发病率呈上升趋势,峰值为1.21 / 10万。患者主要为老年人(78岁)、男性(82.6%)和糖尿病患者(71.7%)。铜绿假单胞菌感染占82.2%,其次是高真菌感染(64.4%)和多微生物感染(71.1%)。高龄、颅神经病变和疾病进展预测不良结局(P < 0.05)。培养阴性与颅底疾病晚期相关(P = 0.045)。本土患者(19.5%)明显更年轻(P < 0.001),共病负担相当(P = 0.719)。总复发率为21.7%。结论:北昆士兰NOE发病率正在上升,这是由高危人群中不同的热带和社会决定因素驱动的。由于发病率增加和复发率高,需要进一步研究以改善高危社区的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Otology & Neurotology
Otology & Neurotology 医学-耳鼻喉科学
CiteScore
3.80
自引率
14.30%
发文量
509
审稿时长
3-6 weeks
期刊介绍: ​​​​​Otology & Neurotology publishes original articles relating to both clinical and basic science aspects of otology, neurotology, and cranial base surgery. As the foremost journal in its field, it has become the favored place for publishing the best of new science relating to the human ear and its diseases. The broadly international character of its contributing authors, editorial board, and readership provides the Journal its decidedly global perspective.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书